Old Web
English
Sign In
Acemap
>
authorDetail
>
Fernando Dangond
Fernando Dangond
Merck KGaA
Medicine
Lesion
Internal medicine
IL-2 receptor
Cytotoxic T cell
3
Papers
28
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Evobrutinib Efficacy is Maintained Over Two Years in an Open-label Phase II Study Extension in Patients with Relapsing Multiple Sclerosis (4124)
2021
Neurology
Xavier Montalban
Douglas L. Arnold
Martin S. Weber
Ivan Staikov
Karolina Piasecka-Stryczyńska
Emily Martin
Matthew Mandel
Fernando Dangond
Jerry S. Wolinsky
Show All
Source
Cite
Save
Citations (1)
Immunologic and MRI markers of the therapeutic effect of IFN-β-1a in relapsing-remitting MS
2015
Neuroimmunology and Neuroinflammation
Yazhong Tao
Xin Zhang
Robert Zivadinov
Michael G. Dwyer
Cheryl Kennedy
Niels Bergsland
Deepa P. Ramasamy
Jacqueline Durfee
David Hojnacki
Brooke Hayward
Fernando Dangond
Bianca Weinstock Guttman
Silva Markovic-Plese
Show All
Source
Cite
Save
Citations (13)
Effect of Treatment with Interferon Beta-1a on Changes in Voxel-Wise Magnetization Transfer Ratio in Normal Appearing Brain Tissue and Lesions of Patients with Relapsing–Remitting Multiple Sclerosis: A 24-Week, Controlled Pilot Study
2014
PLOS ONE
Robert Zivadinov
Michael G. Dwyer
Silva Markovic-Plese
Cheryl Kennedy
Niels Bergsland
Deepa P. Ramasamy
Jacqueline Durfee
David Hojnacki
Brooke Hayward
Fernando Dangond
Bianca Weinstock Guttman
Show All
Source
Cite
Save
Citations (14)
1